| Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice C Zhang, M Zhang, S Wang, R Han, Y Cao, W Hua, Y Mao, X Zhang, ... The ISME journal 4 (2), 232-241, 2010 | 1238 | 2010 |
| Apolipoprotein AI stimulates AMP-activated protein kinase and improves glucose metabolism R Han, R Lai, Q Ding, Z Wang, X Luo, Y Zhang, G Cui, J He, W Liu, ... Diabetologia 50 (9), 1960-1968, 2007 | 179 | 2007 |
| Regulation of adiponectin receptors in hepatocytes by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone X Sun, R Han, Z Wang, Y Chen Diabetologia 49 (6), 1303-1310, 2006 | 62 | 2006 |
| Maternal low-protein diet up-regulates the neuropeptide Y system in visceral fat and leads to abdominal obesity and glucose intolerance in a sex-and time-specific manner R Han, A Li, L Li, JB Kitlinska, Z Zukowska The FASEB Journal 26 (8), 3528, 2012 | 46 | 2012 |
| The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of adrenergic-induced lipolysis C Cero, M Razzoli, R Han, BS Sahu, J Patricelli, ZK Guo, NA Zaidman, ... Molecular metabolism 6 (1), 148-158, 2017 | 43 | 2017 |
| Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation R Han, X Wang, W Bachovchin, Z Zukowska, JW Osborn Scientific Reports 5 (1), 12348, 2015 | 37 | 2015 |
| Stress Hormone Epinephrine Enhances Adipogenesis in Murine Embryonic Stem Cells by Up-Regulating the Neuropeptide Y System R Han, JB Kitlinska, WR Munday, GI Gallicano, Z Zukowska PLoS ONE 7 (5), e36609, 2012 | 35 | 2012 |
| Negative regulation of adiponectin receptor 1 promoter by insulin via a repressive nuclear inhibitory protein element X Sun, J He, C Mao, R Han, Z Wang, Y Liu, Y Chen FEBS letters 582 (23-24), 3401-3407, 2008 | 33 | 2008 |
| Renal denervation normalizes arterial pressure with no effect on glucose metabolism or renal inflammation in obese hypertensive mice N Asirvatham-Jeyaraj, JK Fiege, R Han, J Foss, CT Banek, BJ Burbach, ... Hypertension 68 (4), 929-936, 2016 | 28 | 2016 |
| Peptide/receptor co-evolution explains the lipolytic function of the neuropeptide TLQP-21 BS Sahu, P Rodriguez, ME Nguyen, R Han, C Cero, M Razzoli, P Piaggi, ... Cell reports 28 (10), 2567-2580. e6, 2019 | 23 | 2019 |
| The TLQP‐21 neuropeptide and the complement 3a receptor (C3aR1) regulate a novel prolipolytic pathway BS Sahu, C Cero, R Han, M Razzoli, SO Grady, A Bartolomucci The FASEB Journal 32, 605.10-605.10, 2018 | | 2018 |
| Renal denervation lowers mean arterial pressure in obese female Schlager mice but adversely affects glucose metabolism N Asirvatham‐Jeyaraj, CT Banek, MM Gauthier, R Han, M Razzoli, ... The FASEB Journal 31, 720.6-720.6, 2017 | | 2017 |
| Renal denervation normalizes blood pressure and improves glucose metabolism in obese genetically hypertensive Schlager mice N Asirvatham‐Jeyaraj, CT Banek, R Han, M Razzoli, BJ Burbach, ... The FASEB Journal 30, 962.9-962.9, 2016 | | 2016 |
| High fat diet induced hypertension and impaired glucose tolerance in the Obesity‐Prone Sprague Dawley rat: Effect of increased salt intake and renal denervation R Han, CT Banek, N Asirvatham‐Jeyaraj, X Wang, J Osborn The FASEB Journal 30, 1006.10-1006.10, 2016 | | 2016 |
| Abstract P051: Renal Denervation Normalizes Arterial Pressure but Has No Effect on Renal Inflammation or Glucose Metabolism in Obese Hypertensive C57bl6j Mice N Asirvatham-Jeyaraj, R Han, J Fiege, J Foss, M Razzoli, BJ Burbach, ... Hypertension 66 (suppl_1), AP051-AP051, 2015 | | 2015 |
| Cardiovascular, Metabolic and Renal T‐cell Profile of Obese C57Bl6 mice: Role of Renal Nerves N Asirvatham‐Jeyaraj, J Fiege, R Han, J Foss, A Bartolomucci, M Razzoli, ... The FASEB Journal 29, 667.1, 2015 | | 2015 |
| Stress‐induced Epigenetic Programming for Adipogenesis, Role of Neuropeptide Y and and Adipose Stem Cells R HAN, J Kitlinska, A Li, C Lumeng, Z Zukowska The FASEB Journal 25, 1062.9-1062.9, 2011 | | 2011 |
| PROGRAMMING FOR METABOLIC SYNDROME: ROLE OF STRESS, NEUROPEPTIDE Y AND ADIPOSE STEM CELLS Z Zukowska, R Han, W Munday, I Gallicano Journal Of Diabetes 1, A45, 2009 | | 2009 |
Shuangwei Li, PhD, DABT, RAC,DSPDirector of Toxicology, Calibr-Skaggs Institute for Innovative Medicines A division of Scripps ReseaVerified email at scripps.edu
